01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2021–FY2026. Drag across the bars to change the range.
- $5.72B
2 older moves run past ±50% (largest +83.1%); point at, tap or drag across the bars to read one.
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2026 | $5.72B | +3.1% | 10-K | |
| FY2025 | $5.55B | +42.9% | 10-K | |
| FY2024 | $3.88B | −18.6% | 10-K | |
| FY2023 | $4.77B | +17.9% | 10-K | |
| FY2022 | $4.05B | −1.1% | 10-K | |
| FY2021 | $4.09B | +2.0% | 10-K | |
| FY2020 | $4.01B | +11.1% | 10-K | |
| FY2019 | $3.61B | −8.4% | 10-K | |
| FY2018 | $3.94B | −9.2% | 10-K | |
| FY2017 | $4.34B | +36.3% | 10-K | |
| FY2016 | $3.18B | +16.4% | 10-K | |
| FY2015 | $2.74B | −4.3% | 10-K | |
| FY2014 | $2.86B | +27.5% | 10-K | |
| FY2013 | $2.24B | −17.8% | 10-K | |
| FY2012 | $2.73B | +29.6% | 10-K | |
| FY2011 | $2.10B | −0.6% | 10-K | |
| FY2010 | $2.12B | +83.1% | 10-K | |
| FY2009 | $1.16B | +71.5% | 10-K | |
| FY2008 | $674.0M | — | 10-K |
03—Questions
What is MCKESSON CORP's current free cash flow?
MCKESSON CORP (MCK) annual free cash flow for 2026 was $5.72B, a 3.08% increase from 2025. MCKESSON CORP free cash flow for the quarter ending March 31, 2026 was $3.31B.
What was MCKESSON CORP's free cash flow in 2025?
MCKESSON CORP annual free cash flow for 2025 was $5.55B, a 42.88% increase from 2024.
What was MCKESSON CORP's free cash flow in 2024?
MCKESSON CORP annual free cash flow for 2024 was $3.88B, a 18.58% decline from 2023.
What is MCKESSON CORP's 5-year free cash flow CAGR?
MCKESSON CORP free cash flow grew at a compound annual growth rate (CAGR) of 6.93% from FY2021 to FY2026, going from $4.09B to $5.72B over 5 years.
- Company
- MCKESSON CORP
- Ticker
- MCK
- Sector
- Healthcare
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries